On May 29, 2013 Allon Therapeutics Inc. filed a Proposal pursuant to Section 62 of the Bankruptcy and Insolvency Act (“BIA”). Documents with regards to these proceedings will be posted to this website.
General and creditor inquiries may be directed to:
Deloitte Restructuring Inc. (formerly Deloitte & Touche Inc.)
2800 - 1055 Dunsmuir St.
Vancouver BC V7X 1P4
Allon Therapeutics Inc.’s press release can be found at: http://www.newswire.ca/en/story/1174649/allon-announces-the-filing-of-a-proposal-with-creditors-and-reorganization
On May 31, 2013 the following documents were mailed to known creditors:
The First Meeting of Creditors (the “Meeting”) regarding the Proposal was held on June 12, 2013. At the Meeting, the Proposal was approved unanimously by the creditors who attended in person, by proxy or voted in advance by voting letter.
An application will be made on July 5, 2013 in the Supreme Court of British Columbia (the “Court”) at 2:00PM for the approval of the Proposal. Posted to this website are:
On June 19, 2013, the Trustee issued a notice to all known creditors that had not yet proven their claims stating that all proof of claim forms (with supporting documentation) must be submitted to the Trustee no later than July 19, 2013 in order to be eligible for a dividend distribution. All claims must be submitted in Canadian dollars converted at the closing exchange rate in effect on the date of the Proposal, May 29, 2013. For ease of reference, the exchange rate on May 29, 2013 was $1.0352CDN/USD. The Trustee will not accept any claims after July 19, 2013.
An Application for the approval of the Proposal was heard by the Court on July 5, 2013 and the following Order was granted approving the Proposal and the Articles of Reorganization, attached as Schedule A to the Proposal:
March 19, 2014 – The Trustee has made the final distribution to creditors and concluded all matters in the estate. On March 19, 2014, the Court made the following Order approving the discharge of the Trustee.
Nov 27, 2020